EG15011A - Optically active 1,4-dihydropyridines,process for their preparation and their use as medicaments - Google Patents

Optically active 1,4-dihydropyridines,process for their preparation and their use as medicaments

Info

Publication number
EG15011A
EG15011A EG80533A EG53380A EG15011A EG 15011 A EG15011 A EG 15011A EG 80533 A EG80533 A EG 80533A EG 53380 A EG53380 A EG 53380A EG 15011 A EG15011 A EG 15011A
Authority
EG
Egypt
Prior art keywords
dihydropyridines
medicaments
preparation
optically active
optically
Prior art date
Application number
EG80533A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of EG15011A publication Critical patent/EG15011A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
EG80533A 1979-09-01 1980-08-30 Optically active 1,4-dihydropyridines,process for their preparation and their use as medicaments EG15011A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2935451A DE2935451A1 (de) 1979-09-01 1979-09-01 Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel

Publications (1)

Publication Number Publication Date
EG15011A true EG15011A (en) 1985-03-31

Family

ID=6079874

Family Applications (1)

Application Number Title Priority Date Filing Date
EG80533A EG15011A (en) 1979-09-01 1980-08-30 Optically active 1,4-dihydropyridines,process for their preparation and their use as medicaments

Country Status (25)

Country Link
US (3) US4510310A (pt)
EP (1) EP0026317B1 (pt)
JP (2) JPS5636455A (pt)
AR (1) AR228576A1 (pt)
AT (1) ATE16101T1 (pt)
AU (1) AU545023B2 (pt)
CA (1) CA1142937A (pt)
CS (1) CS228506B2 (pt)
DD (1) DD154014A5 (pt)
DE (2) DE2935451A1 (pt)
DK (2) DK160549C (pt)
EG (1) EG15011A (pt)
ES (1) ES494614A0 (pt)
FI (1) FI78686C (pt)
GR (1) GR70080B (pt)
HU (1) HU184821B (pt)
IE (1) IE50504B1 (pt)
IL (1) IL60937A (pt)
NO (1) NO159928C (pt)
NZ (1) NZ194805A (pt)
PH (3) PH19749A (pt)
PL (1) PL128310B1 (pt)
PT (1) PT71724B (pt)
SU (1) SU932988A3 (pt)
ZA (1) ZA805372B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts
JPS57200364A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salt
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
GB2111978B (en) * 1981-10-19 1985-05-01 Maruko Pharmaceutical Co 1 4-dihydropyridine compounds
DE3379107D1 (en) * 1982-06-03 1989-03-09 Pierrel Spa Hydroxyimino and alkoxyimino derivatives of 1,4-dihydropyridine, process for the preparation thereof and pharmaceutical composition therefrom
JPS5970667A (ja) * 1982-10-15 1984-04-21 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
JPS59225162A (ja) * 1983-06-03 1984-12-18 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
USRE34618E (en) * 1984-05-22 1994-05-24 Yamanouchi Pharmaceutical Co., Ltd. Injection of nicardinpine hydrochloride and process for the production thereof
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
DE3423105A1 (de) * 1984-06-22 1986-01-02 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung optisch aktiver 1,4-dihydropyridine
JPS6143165A (ja) * 1984-08-07 1986-03-01 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体の製造法
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
JPS61161263A (ja) * 1985-01-09 1986-07-21 Teijin Ltd １，４−ジヒドロピリジンモノエステルモノカルボン酸の製造法
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
DK142287A (da) * 1986-03-27 1987-09-28 Byk Gulden Lomberg Chem Fab Optisk aktive 1,4-dihydropyridinderivater
US4886819A (en) * 1986-08-27 1989-12-12 The Green Cross Corporation Dihydropyridine derivatives and pharmaceutical composition thereof
JPH0686429B2 (ja) * 1986-08-27 1994-11-02 株式会社ミドリ十字 ジヒドロピリジン誘導体
JPH0755955B2 (ja) * 1986-09-10 1995-06-14 日産化学工業株式会社 光学活性なジヒドロピリジン−５−ホスホン酸エステル
HU196755B (en) * 1986-09-16 1989-01-30 Gyogyszerkutato Intezet Process for production of new substituated amilid derivatives and medical compositions containing them
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
WO1988007525A1 (en) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
EP0353238A1 (de) * 1987-03-27 1990-02-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue zwischenprodukte und verfahren
US4889866A (en) * 1987-06-11 1989-12-26 Syntex (U.S.A.) Inc. Arylsulfonyl dihydropyridine derivatives
JPS6429359A (en) * 1987-07-24 1989-01-31 Teijin Ltd 1,4-dihydropyridine derivative and production thereof
DE3821334A1 (de) * 1988-06-24 1989-12-28 Bayer Ag 1,4-dihydropyridin-threonin-derivate, verfahren zu ihrer herstellung, zwischenprodukte und ihre verwendung als arzneimittel
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
DE4011106A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
AT399718B (de) * 1992-04-16 1995-07-25 Lek Tovarna Farmacevtskih Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
ES2096179T3 (es) * 1992-10-30 1997-03-01 Bayer Ag Dihidropiridinas sustituidas en la posicion 4 con un heterociclilfenilo.
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
ES2193148T3 (es) 1993-12-10 2003-11-01 Bayer Ag 1,4-dihidropiridinas sustituidas con fenilo con actividad cerebral.
US5478848A (en) * 1994-01-26 1995-12-26 Bayer Corporation Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
DE19532320A1 (de) * 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US20100247646A1 (en) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Extended release tablets of nisoldipine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel

Also Published As

Publication number Publication date
PL226503A1 (pt) 1982-05-24
DK368480A (da) 1981-03-02
US4510310A (en) 1985-04-09
IE50504B1 (en) 1986-04-30
PH19006A (en) 1985-12-03
FI78686B (fi) 1989-05-31
IE801820L (en) 1981-03-01
EP0026317A1 (de) 1981-04-08
NO159928B (no) 1988-11-14
JPS5636455A (en) 1981-04-09
DK164158C (da) 1992-10-12
DK241390D0 (da) 1990-10-05
US4988717A (en) 1991-01-29
ES8104228A1 (es) 1981-04-16
PT71724B (en) 1981-06-17
DD154014A5 (de) 1982-02-17
IL60937A (en) 1984-02-29
HU184821B (en) 1984-10-29
GR70080B (pt) 1982-07-27
DE2935451A1 (de) 1981-03-19
NZ194805A (en) 1984-05-31
PL128310B1 (en) 1984-01-31
ES494614A0 (es) 1981-04-16
AU545023B2 (en) 1985-06-27
SU932988A3 (ru) 1982-05-30
PH19749A (en) 1986-06-23
NO802446L (no) 1981-03-02
FI78686C (fi) 1989-09-11
EP0026317B1 (de) 1985-10-16
AU6198280A (en) 1982-03-25
ATE16101T1 (de) 1985-11-15
IL60937A0 (en) 1980-10-26
AR228576A1 (es) 1983-03-30
JPH05310694A (ja) 1993-11-22
PH17914A (en) 1985-01-25
US4849433A (en) 1989-07-18
DK160549C (da) 1991-09-16
FI802717A (fi) 1981-03-02
CA1142937A (en) 1983-03-15
PT71724A (en) 1980-09-01
DK241390A (da) 1990-10-05
JPH07600B2 (ja) 1995-01-11
DK164158B (da) 1992-05-18
CS228506B2 (en) 1984-05-14
NO159928C (no) 1989-02-22
DE3071186D1 (en) 1985-11-21
DK160549B (da) 1991-03-25
ZA805372B (en) 1981-09-30

Similar Documents

Publication Publication Date Title
EG15011A (en) Optically active 1,4-dihydropyridines,process for their preparation and their use as medicaments
DE2861428D1 (en) Optically active compounds, process for their preparation, and their application in the protection of plants
DE3060330D1 (en) Azolyloxy-acetamides, process for their preparation and their use as herbicides
DE3065026D1 (en) Phenylsulphonamide derivatives, a process for their preparation and their use as medicines
IL60127A0 (en) 2-phenyl-alk-1-enyl-cyclopropane-carboxylic acid esters,their preparation and their use as insecticides and acaricides
GR60791B (en) 2',3',6'-trichlor-4-cyano-4'-benzoylureido-diphenylether,preparation process and use thereof as insecticides
DE2963203D1 (en) Urea derivatives, process for their preparation and their use as insecticides
ZA77372B (en) 1,2-benzisothiazolin-3-ones,processes for their preparation and their use as medicaments
IL61371A (en) Medicaments containing phenyloxoalkanoic acids,some new such acids and processes for their preparation
EP0255601A3 (en) Dialkylnaleinimides, process for their preparation and their use as herbicide
DE2960238D1 (en) N-azolylalkyl-halogenoacetanilides, process for their preparation and their use as herbicides
DE3162269D1 (en) 3,6-dimethyl-oct-1-in-3-ols and -oct-1-en-3-ols and derivatives thereof, their use as fragrances and process for preparing 3,6-dimethyl-octan-3-ol
GB1538705A (en) 1,4-dihydropyridine-sugar derivatives process for their preparation and their use as medicaments
IL59760A0 (en) 7-oxo-4-thia-1-aza-bicyclo(3,2,0)-heptane-2-carboxylic acid derivatives,and process for their preparation
ZA805390B (en) Substituted quinolinone-alkanecarboxylic acids, their preparation and use, and medicaments containing them
ZA793336B (en) Novel phenylpiperidine derivatives,processes for their preparation,pharmaceutical preparations containing these derivatives and their use
DE3064716D1 (en) Substituted 2-amino-3,4-dihydropyridine derivatives, their preparation and use as medicaments
ZA856402B (en) Process for the preparation of optically active,substituted 1,4-dihydropyridines and their use as medicaments
EG14295A (en) N-oximinoalkyl-anilides,process for their preparation and their use as fungicides
IL90004A0 (en) 5-fluoromethyl pyrimidine-2-sulfonamides,process for their preparation and composition for their use as herbicides
EP0042092A3 (en) 1,4-dihydropyridine-4-carboxamides, process for preparing them, their use as medicines and preparation thereof
IL60944A (en) 3,4-disubstituted-1,2,5-thiadiazole-1-oxides and 1,1 dioxides,process for their preparation and pharmaceutical compositions comprising them
DE3060211D1 (en) Tetrachlorophthalamic acids, process for their preparation and their bactericidal use
DE3069901D1 (en) Optically active cephalosporin analogs, process for their preparation and their use
ZA801868B (en) Benzenesulfinamides,a process for the preparation thereof and their use as medicaments